Scientific Research News
News about theoretical and practical scientific research spanning a wide variety of disciplines, including engineering, computer science, biology, physics and chemistry. Includes information about research facilities, funding, resources and public policy.
Alevea Mental Health Advocates for Psychedelic Therapy, Citing MAPS' Latest Research and Its Own Success with Ketamine Treatment
Alevea Mental Health fully endorses psychedelic therapy as an effective mental health treatment, following the recent publication of MAPS' Phase 3 study on MDMA-assisted therapy for PTSD. Alevea has already reported significant success in alleviating symptoms of anxiety, depression, and PTSD through its own Ketamine treatment programs. CEO Topher Bradshaw expressed astonishment at the remarkable patient improvements, particularly when other treatments had failed. - September 20, 2023 - Alevea Mental Health
Nanocellect Biomedical Welcomes Peter Vander Horn as Senior VP of Research & Development
NanoCellect Biomedical, a leading pioneer in gentle microfluidic cell sorting technologies, is thrilled to announce the addition of Peter Vander Horn, PhD. to their executive team as Senior Vice President of Research & Development. With an illustrious career marked by groundbreaking... - September 19, 2023 - NanoCellect Biomedical
Mission Microwave Announces One-Kilowatt Ku-Band SSPA/BUC for Satellite Gateways and Teleports
Leading manufacturer of Solid State Power Amplifiers announces a one-kilowatt Ku-Band Block Upconverter, enabling teleports and satellite gateways to take advantage of the reliability and efficiency offered by Gallium Nitride (GaN) amplifiers in a compact hub-mount design. - September 12, 2023 - Mission Microwave
Creative Diagnostics Launches Antimicrobial Synergy Testing Services
Creative Diagnostics has recently launched a series of Antimicrobial Synergy Testing Services to the reserch community. - September 06, 2023 - Creative Diagnostics
The Ohio State University to Offer an Online Corrosion Short Course Fall 2023
Gamry Instruments is proud to sponsor an online Corrosion Short Course to be presented by The Ohio State University. The course is scheduled for October 16, 2023 - November 17, 2023. Registration is now open. - August 24, 2023 - Gamry Instruments
MPFI’s Wang Lab Awarded $1M Grant to Study Mechanism Behind Memory Decline in Alzheimer’s
Memory loss is one of the most devastating effects of Alzheimer's disease, yet the mechanisms behind it remain a mystery. MPFI is working to change that through a new $1,038,819 research award from the National Institute on Aging of the NIH. - August 23, 2023 - Max Planck Florida Institute for Neuroscience
Huntington Study Group Welcomes FDA Approval of New Drug for Chorea in Huntington’s Disease
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in clinical trials for Huntington’s disease (HD), today shares that the Phase 3 pivotal KINECT®-HD study conducted by HSG in collaboration with Neurocrine Biosciences,... - August 18, 2023 - Huntington Study Group
Huntington Study Group Announces Positive Topline Results for Virtual Unified Huntington’s Disease Rating Scale® (vUHDRS®) Study
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), today announces positive topline results from its Virtual Unified Huntington’s Disease Rating Scale®... - August 14, 2023 - Huntington Study Group
Gold Sponsor Orbica Supports the Space for Planet Earth Challenge 2023
SpaceBase, a New Zealand based education and consulting social enterprise, announces partnership with Orbica Global Limited. Orbica will be providing the use of their geospatial data platform. AWS, through Orbica will provide cloud compute access. Both organizatons are the latest in-kind sponsors of the Space for Planet Earth Challenge 2023. - August 14, 2023 - SpaceBase Limited
The FOXG1 Research Foundation Appoints Dr. Soo-Kyung Lee as Chief Scientific Officer to Lead Therapeutics for FOXG1 Syndrome, an Autism-related Rare Disease
The FOXG1 Research Foundation (FRF), a parent-led rare disease patient organization focused on driving therapeutics for FOXG1 syndrome, an Autism-related neurological condition, announced today the appointment of Dr. Soo-Kyung Lee as the new Chief Scientific Officer of the FOXG1 Research Foundation (FRF). Dr. Lee’s dedication to curing FOXG1 syndrome is deeply personal as a mother to Yuna, diagnosed with FOXG1 syndrome in 2009. - August 12, 2023 - FOXG1 Research Foundation
Creative Diagnostics Announces New Antimicrobial Susceptibility Testing Services
Creative Diagnostics announced the launch of its new Antimicrobial Susceptibility Testing (AST) services. - August 06, 2023 - Creative Diagnostics
The ALS Therapy Development Institute and Unite Genomics Partner to Integrate Electronic Health Records Into the ALS Research Collaborative
The ALS Therapy Development Institute (ALS TDI) is partnering with Unite Genomics, a leading healthcare data analytics company, to integrate electronic health record (EHR) data into the ALS Research Collaborative (ARC) via Unite Genomics’ state-of-the-art healthcare data access and analytics... - August 02, 2023 - ALS Therapy Development Institute
Huntington Study Group and CHDI Foundation Collaborate on Enroll-HD
HSG Clinical Research, Inc. - the Huntington Study Group’s clinical research organization (CRO) and wholly owned subsidiary (collectively referred to here as HSG) - has begun providing CRO services for CHDI Foundation’s Enroll-HD observational study and clinical research platform in the... - July 25, 2023 - Huntington Study Group
Cayman and Navinci Announce Strategic Partnership, Expanding Access to Next-Generation Tools for Spatial Proteomics
Cayman and Navinci have partnered to bring next-generation proximity ligation-based solutions for spatial proteomics to US and Canada-based researchers. - July 13, 2023 - Cayman Chemical Company
ABA Technologies’ Adam Hockman Receives 2023 SABA Award
Adam Hockman, Chief Learning Architect at ABA Technologies, Inc. (ABA Tech), receives a Public Awareness Grant from the Society for the Advancement of Behavior Analysis (SABA). SABA’s Public Awareness Grant is awarded to projects that are “designed to deliver messaging focused on... - July 12, 2023 - ABA Technologies, Inc.
Creative Diagnostics Introduces qPCR Assay for Rapid Virus Detection and Quantification
Creative Diagnostics has introduced its new qPCR Assay to the research community. - July 07, 2023 - Creative Diagnostics
UserWise, LLC Celebrates Role in Norlase Obtaining 510(k) Clearance and CE Mark Approval
UserWise, LLC, a San Jose-based human factors consultancy, is pleased to announce its instrumental role in obtaining FDA 510(k) clearance and CE Mark approval for the Norlase ECHO™ Green Pattern Laser photocoagulator. UserWise began working with Norlase in 2018 to develop and execute the... - June 23, 2023 - UserWise, LLC
International LabAutomation Day is June 21
Celebrating Lab Automation; Laboratory automation refers to the use of technology, equipment, and software to streamline and optimize laboratory processes and operations. It involves automating repetitive tasks, data collection and analysis, sample handling, and other activities in a laboratory setting. By leveraging various automated systems, laboratories can enhance efficiency, accuracy, reproducibility, and throughput while reducing human error and the time required to perform experiments. - June 20, 2023 - Laboratory Robotics Interest Group (LRIG)
Creative Diagnostics Announces the Launch of Radial Immunodiffusion Testing Service
Creative Diagnostics has launched its new Single Radial Immunodiffusion Testing services for the biological industry. - June 09, 2023 - Creative Diagnostics
Hemanext Announces a Strategic Partnership and Investment from Vitalant
Partnership to include research and development at Vitalant Innovation Center. - June 07, 2023 - Hemanext
PharmStars Announces “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface” Theme for its Fall 2023 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, is accepting applications for its Fall 2023 cohort around the theme “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.” The cohort is open to startups with digital health solutions that pharma can use to innovate therapeutic supply chain management, medication delivery, or the patient-drug experience for small molecules, biologics, or advanced therapies. Applications are due July 10, 2023. - June 06, 2023 - PharmStars
New Research Benchmarks Biopharmaceutical Perceptions of Global CRO Thought Leadership
Landmark Research Analyzes Perspectives of US and EU Biopharma C-Suite, Clinical Operations and Medical/Regulatory Affairs Professionals on Global CRO Thought Leadership. - June 01, 2023 - Life Science Strategy Group, LLC
Huntington Study Group Announces Call for Abstracts for 30th Annual Meeting
The Huntington Study Group (HSG), with a mission of accelerating treatments that make a difference for those impacted by Huntington’s disease, together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease... - June 01, 2023 - Huntington Study Group
Clubhouse International Launches US Advocacy Campaign This Mental Health Awareness Month
Clubhouse International recognizes May as Mental Health Awareness Month by hosting several awareness-raising initiatives including the launch of a US Advocacy and Awareness campaign, Healing Minds, Powering Communities, in partnership with Fountain House NY, and other US advocacy organizations that aims to effect policy change and increase funding for mental health services. - May 25, 2023 - Clubhouse International
Creative Diagnostics Introduces Viral Replicon Assay Service to Support Virology Research
Creative Diagnostics recently introduced a series of Viral Replicon Assay services to assist researchers in identifying and studying viruses. - May 20, 2023 - Creative Diagnostics
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine for the Treatment of Chorea Associated with Huntington’s Disease in The Lancet Neurology. - Statistically Significant Improvement in Chorea Associated with Huntington’s Disease... - May 19, 2023 - Huntington Study Group
Huntington Study Group Achieves Last Patient Last Visit for Its Observational Study to Test Virtual Use of the Unified Huntington’s Disease Rating Scale®
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., announces an important milestone in the novel observational study Virtual Unified Huntington’s Disease Rating Scale (vUHDRS™). The last participant completed the last visit, marking... - May 16, 2023 - Huntington Study Group
Creative Biolabs: Going Above and Beyond to Advance Immunology Discovery
Creative Biolabs updated strategies in order to help achieve success in immunotherapy discovery. - May 10, 2023 - Creative Biolabs
MPFI Researcher Receives Prominent Award to Launch New Lab
The Max Planck Florida Institute for Neuroscience announces that Dr. Madineh Sarvestani has been named a Freeman Hrabowski Scholar by the Howard Hughes Medical Institute. The award provides up to $8.6 million for five to 10 years to support outstanding early-career faculty members who have strong potential to become leaders in the field and who are committed to advancing diversity, equity, and inclusion in science through their mentorship of trainees from populations underrepresented in science. - May 09, 2023 - Max Planck Florida Institute for Neuroscience
150 Next-Generation Bionic Arm Prostheses from CF Dopomogator Founded by Olena Chernovolova
Charity foundation Dopomogator (founded by Olena Chernovolova) and Allbionics.io team have announced the launch of a bionic prosthetics project for Ukrainians who have lost limbs during the war. According to the founder of the Found, Olena Chernovolova, the goal of the project is to return adults and children who have become victims of the war to a full life. - May 05, 2023 - Dopomogator
Northern College and the Canadian College of Naturopathic Medicine Announce Collaboration
Memorandum of Understanding underscores current need to increase access for health care learners and develop health care resources in northern communities - May 03, 2023 - Canadian College of Naturopathic Medicine
Cyclists Ride Through MA, NH, and ME in Tri-State Trek to Benefit ALS Research
June 24-25, cyclists of all levels are invited to participate in the Tri-State Trek, a New England cycling event raising funds for cutting-edge research to end ALS. - May 03, 2023 - ALS Therapy Development Institute
New Traceable Opioid Material® Kit Expands Coverage to Other Emerging Drugs of Concern in Seized Samples and Toxicological Casework
Cayman Chemical and the Centers for Disease Control and Prevention (CDC) have released a new addition to the Traceable Opioid Material® Kits (TOM Kits®) product line that expands testing laboratory capabilities beyond synthetic opioids to include additional emerging drugs of abuse that are commonly found as co-drugs in fentanyl-containing samples. - April 30, 2023 - Cayman Chemical Company
Recent Findings on Perceived Out-of-Body Experiences Raise New Scientific Questions
All of these findings not only add to the current literature on OBEs and near-death experiences, but also point out important dilemmas and raise some new questions. - April 30, 2023 - The NDE OBE Research Project
Creative Diagnostics Introduces Virus Yield Reduction Assay Service
Creative Diagnostics introduced the Virus Yield Reduction Assay Service to support researchers in evaluating the antiviral activity of compounds. - April 29, 2023 - Creative Diagnostics
NanoCellect Biomedical Announces New Distribution Partnerships in Asia and Europe
NanoCellect Biomedical, the leading provider of microfluidic flow cytometry platforms, has announced new distributor partnerships in Asia and Europe to expand its global reach and provide greater accessibility to its innovative technologies. - April 26, 2023 - NanoCellect Biomedical
Code Tenderloin New Partnership/Internship with Renegade.Bio and Tougaloo College
Code Tenderloin is a non-profit that provides dignity and opportunity through intense job readiness and workforce development program serving those in need. Through barrier removal, we can serve those in life transitions with jobs, education, training, and connections to our referral network of housing, health, reentry programs, and child care services. - April 18, 2023 - Code Tenderloin
Thermo Fisher Partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio
ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with Thermo Fisher’s robust... - April 17, 2023 - ALPCO
ProMedix Inc. Awarded Competitive Grant from the U.S. National Science Foundation
ProMedix Inc. has been awarded a U.S. National Science Foundation (NSF) Small Business Technology Transfer (STTR) grant for $250,000.00 to conduct research and development (R&D) work on improving outcomes from sepsis through active digital monitoring of peripheral blood flow. Impaired... - April 17, 2023 - ProMedix Inc.
Plan to Use Wild Horses for Wildfire Fuel Mitigation Characterized as "Innovative Approach" by AM Best TV
California nonprofit's nature-based wildfire solution recently garnered the attention of AM Best TV, which provides mission critical information to Insurance companies. - April 12, 2023 - Wildhorse Ranch Productions
Black Students in Pittsburgh 3-D Print Living Artery as Part of C-3PO Project
In the C-3PO project of The Citizen Science Lab, African American high school and middle school students have 3-D printed their first living body part. - April 12, 2023 - The Citizen Science Lab
Trent University and Canadian College of Naturopathic Medicine Partner to Create New Pathways to Careers in Holistic Healthcare
Memorandum of Understanding Establishes Partnership for Innovative Research and Program Collaboration - April 11, 2023 - Canadian College of Naturopathic Medicine
Expanded Analytical Chemistry Lab at Covalent Provides Comprehensive Testing for Solids and Liquids
A new ICP-OES and microwave digestor at Covalent Metrology round out its chemistry laboratory to deliver complete, modern chemical analysis for solid and liquid samples. - April 06, 2023 - Covalent Metrology
HSG and HD-CAB Collaborate to Provide Global Patient Advisory Board
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), recently collaborated with Huntington’s Disease – Community Advisory Board (HD-CAB) to provide a... - March 30, 2023 - Huntington Study Group
New Research on Decentralized Clinical Trial (DCT) Strategies to Boost Patient Diversity
Current and Future Clinical Trial Participants Link Enhanced Diversity and Inclusion of Underrepresented Patient Populations to DCT - March 29, 2023 - Life Science Strategy Group, LLC
HSG Announces 30th Annual Meeting
The Huntington Study Group (HSG), a world leader in conducting clinical trials and providing educational programming for Huntington’s disease (HD), recently announced that their 2023 Annual Meeting will be held November 2-4, 2023 at the Sheraton Grand at Wild Horse Pass in Chandler, AZ, a... - March 21, 2023 - Huntington Study Group
Diversity in Clinical Trials Summit 2023
Upcoming Diversity in Clinical Trials Summit Aims to Address Disparities and Improve Patient Outcomes. - March 20, 2023 - Sonar Clinical Research
New Book from Oaklea Offers a Solution to the Scourge of Racism
A new book just released by The Oaklea Press presents a case that racism is endemic in America due to erroneous beliefs prevalent in the national psyche perpetuated by outdated nineteenth century scientific theories still taught in schools, and that it can be cured by propagating the truth. - March 20, 2023 - The Oaklea Press
Gallant Deepens Its Bench by Adding Dr. Valentine Williams as Senior Vice President of Clinical Development and Regulatory
Furthering its mission to bring regenerative medicine to all pets, animal biotech company Gallant Therapeutics welcomes an industry leader, Dr. Val Williams, to its pioneering team. - March 17, 2023 - Gallant
Breaking Barriers: ALS TDI Unveils Groundbreaking ALS Research Collaborative (ARC) to Accelerate Global Research in ALS
The ALS Research Collaborative will revolutionize ALS research by providing scientists with unprecedented access to the data and tools they need to discover new treatments and accelerate progress toward cures for ALS. - March 15, 2023 - ALS Therapy Development Institute